menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Pharma and Biotech Industries Pursue Treatments for Cardiac Inflammation

Program Information
Recommended
Pharma and Biotech Industries Pursue Treatments for Cardiac Inflammation
RestartResume
A treatment for atherosclerosis and the chronic inflammation in arterial blood vessels could be entering critical clinical trial stages t...
  • Overview

    A treatment for atherosclerosis and the chronic inflammation in arterial blood vessels could be entering critical clinical trial stages that may result in a novel new treatment. Dr. Lawrence Cohen, president and chief executive officer of VIA Pharmaceuticals lays out for host Chicago Tribune's Bruce Japsen the landscape of large pharmaceutical companies as well as smaller biotech companies that are making progress in bringing these treatments through the clinical trial process. They are closer than you might think.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 11/19/19

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.